• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID Back to Search Results
Catalog Number SEBX-7-40-135
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Chest Pain (1776); Thrombus (2101); Perforation of Vessels (2135); Device Embedded In Tissue or Plaque (3165)
Event Date 06/17/2016
Event Type  Injury  
Manufacturer Narrative
Event date: date of article publication (b)(4) surgical management for retained distal embolic protection device and fractured guidewire after carotid artery stenting journal of surgical case reports (2016) 6:1¿3 10.1093/jscr/rjw105.If information is provided in the future, a supplemental report will be issued.
 
Event Description
A (b)(6) male in (b)(6) underwent carotid artery stenting(cas) via transfemoral approach for severe (>90%) asymptomatic right internal carotid artery (ica) stenosis.A 5-mm spiderfx distal filter embolic protection device (epd) and a protégé 8 × 30 mm rx stent were used for the procedure.During deployment, this stent inadvertently migrated cephalad and became lodged onto the epd.Despite multiple attempts, the epd was unable to be retrieved with the capture sheath.The physicians placed another 7 × 40 mm protégé rx stent in the right ica to compress the epd and guidewire against the arterial wall, which was placed at the c1¿c2 vertebral level, superior to the first implanted protégé stent.At time of discharge, the ica stenosis had not been resolved.One month after discharge, the patient began experiencing substernal chest pain radiating to the neck with right suborbital pain.It was discovered that the guidewire had fragmented into three pieces.Upon presentation, the patient had moderate (55%) stenosis in the right common carotid artery (cca) and severe (90%) stenosis in the ica.The inferior fragment (known as fragment c) extended from the right femoral artery to the thoracic aorta, where it punctured the proximal aortic arch wall.Thrombus had also formed along the entire 1-meter length of fragment c.Carotid endarterectomy (cea) was performed at the right ica, after which the first stent was cut open longitudinally and excised.The second stent had accrued significant thrombotic material since the initial stenting procedure, so it could not be removed safely.So, the second stent and the edp were left intact.The second stent was anchored to the artery using prolene sutures.After 1-week recovery in icu, the patient returned to the or for removal of the fragment known as fragment c as it was piercing the aortic arch.This was done without incidence.After surgery, the patient reported alleviation of his symptoms.30 months post-operatively, the second stent is still in place.Over 3 years after surgery, no complications have been reported.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROTEGE RX CAROTID STENT SYSTEM
Type of Device
STENT, CAROTID
Manufacturer (Section D)
COVIDEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8227388
MDR Text Key132394896
Report Number2183870-2019-00012
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P060001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 03/27/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/08/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberSEBX-7-40-135
Was Device Available for Evaluation? No
Date Manufacturer Received03/26/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age57 YR
-
-